Eurointervention

Article	Citations
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity	186
Transcatheter left ventriculoplasty	155
In search of the origin of the acronym TAVI	145
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis	139
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s	113
Double-tap to treat paravalvular leak in high-risk annuli	97
Adjunctive pharmacological strategies for residual risk reduction after myocardial revascularisation	83
Recanalisation of coronary chronic total occlusions	69
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry	65
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement	60
Defer-based non-stenting: a promising approach for STEMI	57
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure	51
Hybrid coronary revascularisation: the best or the worst of both worlds?	49
   Atrial fibrillation and acute coronary syndrome 	49
The “road travelled”: reflections on the transformation of information exchange in a digital age	49
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study	47
One-month DAPT after acute coronary syndrome: too short or not too short?	43
Hertz contact intravascular lithotripsy for calcified coronary artery disease: the PINNACLE-I trial	43
Optical coherence tomography versus angiographic guidance in true unprotected left main bifurcation disease: an OCTOBER substudy	42
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document	41
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve	38
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection	37
Impact of off-hours admissions in STEMI-related cardiogenic shock managed with microaxial flow pump – insights from J-PVAD	36
Redo transcatheter mitral valve replacement in mitral annular calcification	36
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study	35

A novel robotic radiation shielding device for interventional cardiology procedures	35
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes	34
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study	34
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial	33
Invasive functional testing in the cath lab as a routine investigation in INOCA: pros and cons	32
Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement	31
Chordal replacement and annuloplasty in one transfemoral device for degenerative mitral regurgitation	30
Five-year follow-up of transcatheter tricuspid valve replacement with the EVOQUE valve	28
Retrievable scaffold therapy before paclitaxel drug-coated balloon angioplasty in infrapopliteal arteries: one-year outcomes of the DEEPER OUS Study	28
Coronary lithotripsy for the treatment of underexpanded stents: the international multicentre CRUNCH registry	28
Oesophageal and gastric injuries caused by transoesophageal probe manipulation in patients undergoing transcatheter edge-to-edge repair for tricuspid regurgitation	27
Prevalence and outcomes of stent thrombosis with in-stent calcified nodules: substudy from the REAL-ST registry	26
Cerebral embolic protection during transcatheter heart interventions	26
A nationwide analysis of reperfusion therapies for pulmonary embolism in older patients with frailty	26
Shifting focus in bifurcations.	25
Antithrombotic therapy for transcatheter structural heart intervention	25
Optical coherence tomography to visualise the endothelialisation of left atrial appendage occluders	25
ACURATE neo2 versus SAPIEN 3 Ultra for transcatheter aortic valve implantation	25
TAVI patients with bystander coronary artery disease should receive PCI: pros and cons	23
Delayed hospitalisation for heart failure after transcatheter repair or medical treatment for secondary mitral regurgitation: a landmark analysis of the MITRA-FR trial	22
Determinants of adverse outcomes following patent foramen ovale closure in elderly patients	21
Carbon footprint of diagnostic coronary angiography	21
Timing of transcatheter aortic valve implantation in patients with aortic stenosis	20
Is transcatheter aortic valve implantation safe in patients with left ventricular outflow tract calcification?	20
Prevention of left ventricular outflow tract obstruction in transapical mitral valve replacement: the MitraCut procedure	20
The ongoing conundrum of the best care for patients presenting with non-ST-segment elevation acute coronary syndrome	19
Ticagrelor-based antiplatelet therapy after percutaneous coronary intervention in chronic coronary syndrome	19
UNICA − a novel single-stent, double-valve, heterotopic, cross-caval approach for severe tricuspid insufficiency 	18
Transcatheter treatment of bicuspid aortic valve stenosis	18
Changes in non-culprit coronary lesions with PCSK9 inhibitors: the randomised, placebo-controlled FITTER trial	18
TRICURE: first-in-human study of the Topaz transcatheter tricuspid heart valve system	18
Coronary CT as a first-line investigation in chronic coronary syndromes: pros and cons	18
New-onset atrial fibrillation detected by ambulatory ECG monitoring after transcatheter aortic valve implantation	17
FFRangio-guided versus pressure wire-guided PCI: design and rationale of the multicentre, randomised ALL-RISE trial	17
The patent foramen ovale does not spontaneously close in patients aged 60	16
Predictors and clinical impact of worsening left ventricular ejection fraction after mitral transcatheter edge-to-edge repair	15
Near-infrared spectroscopy to predict plaque progression in plaque-free artery regions	15
Three-year outcomes of transcatheter aortic valve implantation for bicuspid versus tricuspid aortic stenosis	15
Diagnostic accuracy of quantitative flow ratio in patients with arrhythmias	15
Targeting inflammation in atherosclerosis: overview, strategy and directions	14
SAPIEN 3 Ultra: better sealing, reduced paravalvular leak and a move in the right direction?	14
Stent underexpansion in the CRUNCH registry: worth cracking?	14
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation	14
Low-dose fibrinolysis during primary percutaneous intervention for preventing no-reflow: stepping back to move forward?	13
Direct oral anticoagulants for ventricular thrombus resolution: pilot trials show reassuring efficacy and safety compared to warfarin	13
Transcatheter aortic valve alignment: substantial progress, remaining gaps	13
Anterior mitral leaflet modification with endoscopic scissors during Tendyne implantation	13
Clinical outcomes of transcatheter mitral valve replacement: two-year results of the CHOICE-MI Registry	12
Impact of chronic kidney disease and diabetes on clinical outcomes in women undergoing PCI	12
Procedural considerations for transcatheter aortic valve-in-valve implantation in a degenerated ACURATE neo prosthesis	11

Letter: Caffeine and fractional flow reserve overestimation: a word of caution	11
Device-related thrombus following left atrial appendage occlusion	11
PCR London Valves - in person or online - an invaluable opportunity for exchange dedicated to advancing the treatment of valvular heart disease	11
Direct oral anticoagulants or warfarin in patients with left ventricular thrombus after ST-elevation myocardial infarction: a pilot trial and a prespecified meta-analysis of randomised trials	11
Changes in absolute coronary flow and microvascular resistance during exercise in patients with ANOCA	10
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interv	10
Optimal timing of aspirin discontinuation with ticagrelor monotherapy in acute coronary syndrome: a post hoc comparative analysis from the TICO and T-PASS trials	10
Skating on thin ice: searching for vulnerable plaques	10
Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies	10
SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women	10
We now have enough evidence to support systematic OCT in daily PCI practice: pros and cons	10
Letter: Complex PCI in severe aortic stenosis: high risk, low reward?	9
A comparison of simplified or conventional antithrombotic regimens after left atrial appendage closure in patients at high bleeding risk: the PLATEBRISK study	9
Transcatheter interventions for heart failure	9
Radiation protection for healthcare professionals working in catheterisation laboratories during pregnancy: a statement of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)	9
Sirolimus-eluting or everolimus-eluting stents for coronary artery disease: 5-year outcomes of the randomised BIOFLOW-IV trial	9
Impact of mitral regurgitation aetiology on the outcomes of transcatheter aortic valve implantation	8
Coronary access after transcatheter aortic valve replacement in bicuspid versus tricuspid aortic stenosis	8
Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation	8
First experience of left atrial appendage occlusion using a 3D mini transoesophageal echocardiographic probe with conscious sedation	8
Reply: Non-culprit plaque rupture in STEMI – marker of vulnerability or actionable risk?	8
Percutaneous Valvular and Structural Heart Disease Interventions.2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with	8
A randomised controlled trial of the Cathpax AIR radioprotection cabin during cardiology procedures	8
Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: final 7-year results of the COMPARE-ABSORB trial	8
Controlled antegrade and retrograde subintimal tracking (CART) for recanalisation of chronic total occlusions	8
Comparison of self-expanding transcatheter heart valves for aortic stenosis: the multicentre, randomised, controlled, non-inferiority DOUBLE-CHOICE trial	8
Commissural alignment with the novel Hydra transcatheter heart valve during aortic valve replacement	7
“Lotus root”: a novel optical coherence tomography imaging pattern in spontaneous coronary artery dissection	7
Changes in post-PCI optimisation strategies with post-procedural FFR followed by IVUS	7
Pulmonary artery denervation – the suspense continues?	7
Timing of coronary angiography in patients with non-ST-elevation acute coronary syndrome: long-term clinical outcomes from the nationwide SWEDEHEART registry	7
Timing of bioprosthetic valve fracture in transcatheter valve-in-valve intervention: impact on valve durability and leaflet integrity	6
Impact of moderate or severe left ventricular outflow tract calcification on clinical outcomes of patients with severe aortic stenosis undergoing transcatheter aortic valve implantation with self- and	6
Temporal patterns, characteristics, and predictors of clinical outcomes in patients undergoing percutaneous coronary intervention for stent thrombosis	6
Safety and efficiency of percutaneous coronary intervention using a standardised optical coherence tomography workflow	6
Transcatheter tricuspid interventions are performed too late: pros and cons	6
Robotic-assisted percutaneous coronary intervention: the future or the past?	5
Microaxial flow pump for high-risk PCI: are we ready for the prime time?	5
Rotational atherectomy combined with cutting balloon to optimise stent expansion in calcified lesions: the ROTA-CUT randomised trial	5
Discontinuation of the ACURATE transcatheter heart valve platform: loss or reckoning?	5
Scores and algorithms in CTO PCI: “PROGRESS” or an exercise in futility?	5
Reply: Beyond frame expansion: interpreting the implications of routine post-dilatation	5
Durability of transcatheter aortic valve implantation in bicuspid aortic valve stenosis: the last missing piece?	5
Radial wall strain: a novel angiographic measure of plaque composition and vulnerability	5
New-onset or newly detected atrial fibrillation after transcatheter aortic valve implantation?	5
Low-flow, low-gradient aortic stenosis: an understanding is still a long way off	5
Histological examination of renal nerve distribution, density, and function in humans	5
Outcomes by sex in the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA) trial	5
Letter: Beyond frame expansion: interpreting the implications of routine post-dilatation	5
Treatment of coronary bifurcation lesions, part II: implanting two stents. The 16th expert consensus document of the European Bifurcation Club	5
Coronary flow and resistance patterns indexed by subtended myocardial mass in coronary microvascular dysfunction	5
Treatment of patent foramen ovale	5
Cost-effectiveness of an FFR-guided strategy during STEMI – no rose without a thorn	4
Periprocedural continuation versus interruption of oral anticoagulant drugs during transcatheter aortic valve implantation: rationale and design of the POPular PAUSE TAVI trial	4
SESAME technique: septal scoring along the midline endocardium	4
The 17th expert consensus document of the European Bifurcation Club – techniques to preserve access to the side branch during stepwise provisional stenting	4
Routine cerebral embolic protection in transcatheter aortic valve implantation: rationale and design of the randomised British Heart Foundation PROTECT-TAVI trial	4
TAVI in asymptomatic patients with severe aortic stenosis: pros and cons	4
ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike	4
Electrosurgical laceration and stabilisation of three clip devices (ELASTA-Clip) to enable transcatheter mitral valve implantation	4
A novel spacer for transcatheter treatment of tricuspid regurgitation	4
Dual-therapy CD34 antibody-covered sirolimus-eluting COMBO stents versus sirolimus-eluting Orsiro stents in patients treated with percutaneous coronary intervention: the three-year outcomes of the SOR	4
Ultrasound-guided femoral access in patients with vascular closure devices: a prespecified analysis of the randomised UNIVERSAL trial	4
Consider aspirin bridging for non-cardiac surgery in patients with coronary stents treated with oral anticoagulation monotherapy	4
Prasugrel monotherapy versus standard DAPT in STEMI patients with OCT-guided or angio-guided complete revascularisation: design and rationale of the randomised, multifactorial COMPARE STEMI ONE trial	4
Transcatheter aortic valve implantation of a novel system for severe pure native aortic regurgitation in a patient with an ascending aorta aneurysm	3
Low urine pH: a new marker for contrast-associated acute kidney injury?	3
Will the dream of “leave nothing behind” remain a utopia if we forget to optimise the systemic medical therapy?	3
Clinical outcomes of the ACURATE neo2 transcatheter heart valve: a prospective, multicentre, observational, post-market surveillance study	3
Comprehensive diagnosis in chronic coronary syndromes combining angiography and intracoronary testing: the AID-ANGIO study	3
First-in-human description of a novel transcatheter tricuspid valve prosthesis to preserve the asymmetric shape of the right ventricle	3
Mechanical thrombectomy for pulmonary embolism revisited: technological breakthrough or simple renovation?	3
Quantitative flow ratio versus fractional flow reserve for Heart Team decision-making in multivessel disease: the randomised, multicentre DECISION QFR trial	3
Transcatheter tricuspid valve repair/replacement should be offered to all patients with severe tricuspid regurgitation: pros and cons	3
Stop at the yellow light spot: in vivo detection of preclinical atherosclerosis	3
Balloon-expandable versus self-expanding stents in native coarctation of the aorta: three-year results of a randomised controlled trial 	3
Catheter directed therapies: an option for elderly frail patients with pulmonary embolism requiring reperfusion	3
Prevalence and patterns of in-stent neoatherosclerosis in lower extremity artery disease	3
Ticagrelor monotherapy versus ticagrelor plus aspirin in patients with chronic coronary syndrome and high ischaemic risk: a post hoc analysis of the TWILIGHT trial	3
Feasibility of redo-TAVI in the self-expanding ACURATE neo2 valve: a computed tomography study	3

A prospective, first-in-human use of the NeVa mechanical thrombectomy device for patients with acute coronary syndromes	3
Treatment of severe aortic valve regurgitation with the Trilogy TAVI system	3
VA-ECMO in cardiogenic shock: is the road closed or open?	3
Impact of one-month DAPT followed by aspirin monotherapy in patients undergoing percutaneous coronary intervention according to clinical presentation: a post hoc analysis of the randomised One-Month D	3
Three-year outcomes of A Randomized Multicentre Trial Comparing Revascularization and Optimal Medical Therapy for Chronic Total Coronary Occlusions (EuroCTO)	3
Intravascular ultrasound guidance for lower extremity arterial and venous interventions	3
Reply: Due to the lack of significant mortality benefits along with high procedural complication rates, percutaneous coronary intervention of chronic total occlusions should be discouraged	3
Letter: Pretreatment with unfractioned heparin in patients undergoing primary PCI: a standard of treatment together with DAPT?	3
Women and coronary artery disease: not just underrepresented and underdiagnosed, but also undertreated!	3
Prevalence, classification, and treatment of residual shunt after patent foramen ovale closure	3